Gordon Hamilton

Gordon is the CEO of Depixus. He brings experience of translational research and bioscience commercialization having worked as Medical Director for ChemoCentryx, a successful Silicon Valley biopharmaceutical company.

He has previously also founded and built-up The Electives Network Ltd, an international medical education company. He has a First Class Master’s degree in Physiological Sciences from the University of Oxford, a medical degree from Imperial College School of Medicine, and an MBA from INSEAD.